The Oklahoma Blood Institute is now collecting convalescent plasma from donors who have recovered from COVID-19, part of an experimental initiative approved by the Food and Drug Administration to test the product in treatment of seriously ill patients. Convalescent plasma is the liquid part of blood that is collected from patients ...